CBS and Alzheimer disease: In this multicenter longitudinal cohort study, we explored the clinical utility of plasma p-tau217 for detecting AD in individuals with CBS and found plasma p-tau217 was elevated in patients with CBS with positive amyloid or tau PET results and showed excellent diagnostic performance for identifying PET positivity in this cohort.